Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Driving innovation in India’s pharma R&D through cell and gene therapy
Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre highlights how…
AstraZeneca launches Eculizumab in India
It is now the first anti-complement therapy authorised in India for the treatment of for atypical Haemolytic Uremic Syndrome(aHUS)…
Patent Rule Amendments 2024: Who gained who lost in amendment of FORM 27?
Essay relates to main amendments of 2024 relating to FORM 27, compares with erstwhile requirements to find out who gained and who…
Pharma deal activity declines by 47.5% in August 2025: GlobalData
The GlobalData has revealed that the global pharmaceuticals sector has witnessed a slowdown in deal-making activity in August…
11th Annual Pharma Legal & Compliance Summit 2025 to decode future of pharma, healthcare &…
The 11th Annual Pharma Legal & Compliance Summit (PLCS) 2025, India’s leading platform for legal, regulatory, and compliance…
DIA India Annual Meeting 2025 to focus on innovation, integration, and patient-centric healthcare
DIA, the global organisation of life sciences professionals, will host the DIA India Annual Meeting 2025 on Sept. 19–20 at The…
Strides and Kenox join hands to expand nasal spray portfolio in US market
Strides Pharma Science Ltd has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore…
Akums’ Hormonal Plant receives EAEU GMP certification
Akums Drugs & Pharmaceuticals has received Good Manufacturing Practice (GMP) Certification by the Eurasian Economic Union…
AstraZeneca India launches Eculizumab to treat aHUS and PNH
AstraZeneca India, a leading global biopharmaceutical company has launched Eculizumab concentrate solution for infusion (300 mg,10…
GST 2.0 is a tailwind for India’s Nutraceuticals
The 56th GST Council has recommended a simplified structure with two principal slabs—5% and 18%, plus a 40% “demerit” slab for…